- Home
- TRSG vs GRCE Comparison
TRSG vs GRCE Comparison
Compare TRSG & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- GRCE
- Stock Information
- Founded
- TRSG 1996
- GRCE 2002
- Country
- TRSG Singapore
- GRCE United States
- Employees
- TRSG N/A
- GRCE N/A
- Industry
- TRSG
- GRCE
- Sector
- TRSG
- GRCE
- Exchange
- TRSG NYSE
- GRCE NYSE
- Market Cap
- TRSG 35.2M
- GRCE 30.9M
- IPO Year
- TRSG 2024
- GRCE N/A
- Fundamental
- Price
- TRSG $2.18
- GRCE $3.86
- Analyst Decision
- TRSG
- GRCE
- Analyst Count
- TRSG 0
- GRCE 0
- Target Price
- TRSG N/A
- GRCE N/A
- AVG Volume (30 Days)
- TRSG 17.6K
- GRCE 76.9K
- Earning Date
- TRSG 02-15-2025
- GRCE 12-31-2024
- Dividend Yield
- TRSG N/A
- GRCE N/A
- EPS Growth
- TRSG N/A
- GRCE N/A
- EPS
- TRSG 0.06
- GRCE N/A
- Revenue
- TRSG $14,362,502.00
- GRCE N/A
- Revenue This Year
- TRSG N/A
- GRCE N/A
- Revenue Next Year
- TRSG N/A
- GRCE N/A
- P/E Ratio
- TRSG $35.72
- GRCE N/A
- Revenue Growth
- TRSG N/A
- GRCE N/A
- 52 Week Low
- TRSG $2.06
- GRCE $1.98
- 52 Week High
- TRSG $11.78
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- GRCE N/A
- Support Level
- TRSG N/A
- GRCE N/A
- Resistance Level
- TRSG N/A
- GRCE N/A
- Average True Range (ATR)
- TRSG 0.00
- GRCE 0.00
- MACD
- TRSG 0.00
- GRCE 0.00
- Stochastic Oscillator
- TRSG 0.00
- GRCE 0.00
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.